Protara Therapeutics, Inc. (TARA) Tops Q3 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Wall St set for muted open as tech stocks take a breather
- Oil slips on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mailGet Alerts TARA Hot Sheet
Join SI Premium – FREE
Protara Therapeutics, Inc. (NASDAQ: TARA) reported Q3 EPS of ($0.31), $0.07 better than the analyst estimate of ($0.38).
For earnings history and earnings-related data on Protara Therapeutics, Inc. (TARA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RXO shares soar as C.H. Robinson announces $5.8B cash and stock buyout
- UBS Reiterates Neutral Rating on Tesla (TSLA) as Deliveries Beat Estimates
- CME Group (CME) PT Raised to $300 at TD Cowen on 'Broadening Growth Drivers'
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
